| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date | Match? |
|---|
| Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective | [1]Wael M Elshemey, [2]Abdo A Elfiky, [3]Ibrahim M Ibrahim, [4]Alaa M Elgohary [Full author list] | Computers in Biology and Medicine [missing] | DOI: 10.1016/J.COMPBIOMED.2022.105478 [ORCID]
PubMed: 35421790 [ORCID]
| SARS-CoV-2 [missing] | 2022-04-07 | |
| Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase | [1]Abdo A. Elfiky, [2]Hanan A Mahran, [3]Ibrahim M Ibrahim, [4]Mohamed N Ibrahim, [5]Wael M Elshemey [Full author list] | RSC Advances [missing] | DOI: 10.1039/D1RA07447D [ORCID]
PubMed: 35425333 [ORCID]
| SARS-CoV-2 [missing] | 2022-01-20 | Wael M. Elshemey (Q46575964; 11 items)
|
| Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective | [1]Amr Sonousi, [2]Hanan A Mahran, [3]Ibrahim M Ibrahim, [4]Mohamed N Ibrahim, [5]Abdo A. Elfiky, [6]Wael M Elshemey [Full author list] | Pharmacological Reports [missing] | DOI: 10.1007/S43440-021-00300-9 [ORCID]
PubMed: 34165771 [ORCID]
| SARS-CoV-2 [missing] | 2021-06-24 | Wael M. Elshemey (Q46575964; 11 items)
|
| A possible role for GRP78 in cross vaccination against COVID-19 | [1]Abdo A Elfiky, [2]Ibrahim M Ibrahim, [3]Alaa M Ismail, [4]Wael M Elshemey [Full author list] | Journal of Infection [missing] | DOI: 10.1016/J.JINF.2020.09.004 [ORCID]
PubMed: 32920062 [ORCID]
| COVID-19 [missing] | 2020-09-10 | |
| Recognition of the gluconeogenic enzyme, Pck1, via the Gid4 E3 ligase: An in silico perspective | [1]Alaa M Ismail, [2]Abdo A. Elfiky, [3]Wael M Elshemey [Full author list] | Journal of Molecular Recognition [missing] | DOI: 10.1002/JMR.2821 [ORCID]
PubMed: 31883179 [ORCID]
| | 2019-12-27 | Wael M. Elshemey (Q46575964; 11 items)
|
| Recognition of gluconeogenic enzymes; Icl1, Fbp1, and Mdh2 by Gid4 ligase: A molecular docking study | [1]Abdo A. Elfiky, [2]Alaa M Ismail, [3]Wael M Elshemey [Full author list] | Journal of Molecular Recognition [missing] | DOI: 10.1002/JMR.2831 [ORCID]
PubMed: 31863529 [ORCID]
| | 2019-12-20 | Wael M. Elshemey (Q46575964; 11 items)
|
| Plasma membrane proteins: A new probe for the characterization of breast cancer | [1]Heba M Fahmy, [2]Alaa M Ismail, [3]Amena S El-Feky, [4]Esraa S Abu Serea, [5]Wael M Elshemey [Full author list] | Life Sciences [missing] | DOI: 10.1016/J.LFS.2019.116777 [ORCID]
PubMed: 31465734 [ORCID]
| membrane protein [missing] | 2019-08-26 | |
| Novel inhibitors against wild-type and mutated HCV NS3 serine protease: an in silico study | [1]Ahmed A Ezat, [2]Abdo A. Elfiky, [3]Wael M Elshemey, [4]Noha A Saleh, [5]Noha A Saleh [Full author list] | VirusDisease [missing] | DOI: 10.1007/S13337-019-00516-7 [ORCID]
PubMed: 31179358 [ORCID]
| | 2019-03-21 | Wael M. Elshemey (Q46575964; 11 items)
|
| A comparative study of the efficiency of HCV NS3/4A protease drugs against different HCV genotypes using in silico approaches | [1]Ahmed A Ezat, [2]Wael M Elshemey [Full author list] | Life Sciences [missing] | DOI: 10.1016/J.LFS.2018.12.004 [ORCID]
PubMed: 30528183 [ORCID]
| | 2018-12-04 | |
| Molecular dynamics simulation revealed binding of nucleotide inhibitors to ZIKV polymerase over 444 nanoseconds | [1]Abdo A. Elfiky, [2]Wael M Elshemey, [2-Q46575964]Wael M. Elshemey [Full author list] | Journal of Medical Virology [missing] | DOI: 10.1002/JMV.24934 [ORCID]
PubMed: 28922464 [ORCID]
| Zika virus [missing] | 2017-09-18 | Wael M. Elshemey (Q46575964; 11 items)
|
| Structure-based drug design of novel peptidomimetic cellulose derivatives as HCV-NS3 protease inhibitors | [1]Noha A Saleh, [2]Wael M Elshemey [Full author list] | Life Sciences [missing] | DOI: 10.1016/J.LFS.2017.08.021 [ORCID]
PubMed: 28842311 [ORCID]
| cellulose [missing] | 2017-08-24 | Wael M. Elshemey (Q46575964; 11 items)
|
| Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses | [1]Abdo A. Elfiky, [2]Samah M Mahdy, [3]Wael M Elshemey [Full author list] | Journal of Medical Virology [missing] | DOI: 10.1002/JMV.24736 [ORCID]
PubMed: 27864902 [ORCID]
| Hepatitis C virus [missing]; quantitative structure-activity relationship [missing] | 2016-11-19 | Wael M. Elshemey (Q46575964; 11 items)
|
| IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study | [1]Abdo A. Elfiky, [2]Wael M Elshemey [Full author list] | Medicinal Chemistry Research [missing] | DOI: 10.1007/S00044-016-1533-Y [ORCID]
PubMed: 32214769 [ORCID]
| | 2016-03-04 | Wael M. Elshemey (Q46575964; 11 items)
|
| 2′-Methylguanosine Prodrug (IDX-184), Phosphoramidate Prodrug (Sofosbuvir), Diisobutyryl Prodrug (R7128) Are Better Than Their Parent Nucleotides and Ribavirin in Hepatitis C Virus Inhibition: A Molecular Modeling Study | [1]Abdo A. Elfiky, [2]Wael M. Elshemey, [3]Wissam A. Gawad [Full author list] | Journal of Computational and Theoretical Nanoscience [missing] | DOI: 10.1166/JCTN.2015.3739 [ORCID]
| hepatitis C [missing]; ribavirin [missing]; Hepatitis C virus [missing]; sofosbuvir [missing] | 2015-03-01 | Wael M. Elshemey (Q46575964; 11 items)
|
| Theoretical Study on Modified Boceprevir Compounds as NS3 Protease Inhibitors | [1]Noha A. Saleh, [2]Ahmed A. Ezat, [3]Abdo A. Elfiky, [4]Wael M. Elshemey, [5]Medhat A Ibrahim [Full author list] | Journal of Computational and Theoretical Nanoscience [missing] | DOI: 10.1166/JCTN.2015.3738 [ORCID]
| | 2015-03-01 | Wael M. Elshemey (Q46575964; 11 items)
|
| The Electronic and Quantitative Structure Activity Relationship Properties of Modified Telaprevir Compounds as HCV NS3 Protease Inhibitors | [1]Noha A. Saleh, [2]Abdo A. Elfiky, [3]Ahmed A. Ezat, [4]Wael M. Elshemey, [5]Medhat A Ibrahim [Full author list] | Journal of Computational and Theoretical Nanoscience [missing] | DOI: 10.1166/JCTN.2014.3392 [ORCID]
| | 2014-02-01 | Wael M. Elshemey (Q46575964; 11 items)
|